Cargando…

TIGIT limits immune pathology during viral infections

Co-inhibitory pathways have a fundamental function in regulating T cell responses and control the balance between promoting efficient effector functions and restricting immune pathology. The TIGIT pathway has been implicated in promoting T cell dysfunction in chronic viral infection. Importantly, TI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schorer, Michelle, Rakebrandt, Nikolas, Lambert, Katharina, Hunziker, Annika, Pallmer, Katharina, Oxenius, Annette, Kipar, Anja, Stertz, Silke, Joller, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062903/ https://www.ncbi.nlm.nih.gov/pubmed/32152316 http://dx.doi.org/10.1038/s41467-020-15025-1

Ejemplares similares

Preceding Viral Infections Do Not Imprint Long-Term Changes in Regulatory T Cell Function
por: Rost, Felix, et al.
Publicado: (2020)

Rapid expansion of Treg cells protects from collateral colitis following a viral trigger
por: Schorer, Michelle, et al.
Publicado: (2020)

Chronic viral infections impinge on naive bystander CD8 T cells
por: Barnstorf, Isabel, et al.
Publicado: (2020)

Recognition and Regulation of T Cells by NK Cells
por: Pallmer, Katharina, et al.
Publicado: (2016)

Chronic virus infection compromises memory bystander T cell function in an IL-6/STAT1-dependent manner
por: Barnstorf, Isabel, et al.
Publicado: (2019)

Unraveling virus-induced cellular signaling cascades by label-free quantitative phosphoproteomics
por: Hunziker, Annika, et al.
Publicado: (2022)

Common Features of Regulatory T Cell Specialization During Th1 Responses
por: Littringer, Katharina, et al.
Publicado: (2018)

Mechanisms of TIGIT-driven immune suppression in cancer
por: Kurtulus, Sema, et al.
Publicado: (2014)

NK cells negatively regulate CD8 T cells via natural cytotoxicity receptor (NCR) 1 during LCMV infection
por: Pallmer, Katharina, et al.
Publicado: (2019)

Profiling Virus-Specific Tcf1+ T Cell Repertoires During Acute and Chronic Viral Infection
por: Yermanos, Alexander, et al.
Publicado: (2020)

Asymmetric cell division shapes naive and virtual memory T-cell immunity during ageing
por: Borsa, Mariana, et al.
Publicado: (2021)

CD85k Contributes to Regulatory T Cell Function in Chronic Viral Infections
por: Estrada Brull, Anna, et al.
Publicado: (2020)

Early primed KLRG1(-) CMV-specific T cells determine the size of the inflationary T cell pool
por: Baumann, Nicolas S., et al.
Publicado: (2019)

T Cell Memory in the Context of Persistent Herpes Viral Infections
por: Torti, Nicole, et al.
Publicado: (2012)

Tissue maintenance of CMV-specific inflationary memory T cells by IL-15
por: Baumann, Nicolas S., et al.
Publicado: (2018)

TIGIT in cancer immunotherapy
por: Chauvin, Joe-Marc, et al.
Publicado: (2020)

The Janus Face of Follicular T Helper Cells in Chronic Viral Infections
por: Greczmiel, Ute, et al.
Publicado: (2018)

Editorial overview: Viral immunology before COVID-19
por: Oxenius, Annette, et al.
Publicado: (2022)

Expression of TIGIT/CD155 and correlations with clinical pathological features in human hepatocellular carcinoma
por: Duan, Xiangguo, et al.
Publicado: (2019)

CD4 T Cell Responses in Latent and Chronic Viral Infections
por: Walton, Senta, et al.
Publicado: (2013)

TIGIT-based immunotherapeutics in lung cancer
por: Patel, Akshay J, et al.
Publicado: (2023)

DNAM1 and TIGIT balance the T cell response, with low T cell TIGIT expression corresponding to inflammation in psoriatic disease
por: Jacobs, Marleen E, et al.
Publicado: (2020)

TIGIT is a key inhibitory checkpoint receptor in lymphoma
por: Godfrey, James, et al.
Publicado: (2023)

Dynamic Expressions of TIGIT on Splenic T Cells and TIGIT-Mediated Splenic T Cell Dysfunction of Mice With Chronic Toxoplasma gondii Infection
por: Li, Haoran, et al.
Publicado: (2021)

Expression of the immune checkpoint receptor TIGIT in seminoma
por: Hinsch, Andrea, et al.
Publicado: (2019)

Update in TIGIT Immune-Checkpoint Role in Cancer
por: Annese, Tiziana, et al.
Publicado: (2022)

TIGIT in Lung Cancer: Potential Theranostic Implications
por: Pescia, Carlo, et al.
Publicado: (2023)

TIGIT Can Exert Immunosuppressive Effects on CD8(+) T Cells by the CD155/TIGIT Signaling Pathway for Hepatocellular Carcinoma In Vitro
por: Zhang, Changkun, et al.
Publicado: (2020)

TIGIT(+) iTregs elicited by human regulatory macrophages control T cell immunity
por: Riquelme, Paloma, et al.
Publicado: (2018)

Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target
por: Yángüez, Emilio, et al.
Publicado: (2018)

TIGIT blockade repolarizes AML-associated TIGIT(+) M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis
por: Brauneck, Franziska, et al.
Publicado: (2022)

Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir
por: Pohl, Marie O., et al.
Publicado: (2021)

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer
por: Blessin, Niclas C., et al.
Publicado: (2019)

Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphoma
por: Li, Wenchao, et al.
Publicado: (2018)

Targeting the “PVR–TIGIT axis” with immune checkpoint therapies
por: Gorvel, Laurent, et al.
Publicado: (2020)

Differential expression of the T-cell inhibitor TIGIT in glioblastoma and MS
por: Lucca, Liliana E., et al.
Publicado: (2020)

Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development
por: Rotte, Anand, et al.
Publicado: (2021)

TIGIT as a Promising Therapeutic Target in Autoimmune Diseases
por: Yue, Chenran, et al.
Publicado: (2022)

Discovery of TIGIT inhibitors based on DEL and machine learning
por: Xiong, Feng, et al.
Publicado: (2022)

Expression and Clinical Significance of TIGIT in Primary Breast Cancer
por: Tang, Limin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1c2p9peeesm7lctgf6dgej9co5